Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dentistry, dental veneers, gum treatment, and laser dentistry; dermatology; emergency and general medicine; cochlear implants and balloon sinuplasty; gastroenterology, obesity surgery, and endoscopy and laparoscopy; intensive and critical care; nephrology, urology, kidney transplant, dialysis, and interventional nephrology; and general surgery comprising varicose, hernia, and piles surgery. The company also provides liver transplant; maxillofacial surgery; neur
| Current Price | ₹176.84 |
|---|---|
| Market Cap | ₹1,901 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Assisted Living Facilities and Services |
| P/E Ratio | 54.7 |
| Return on Equity | 3.47% |
| 52-Week Range | ₹125.82 – ₹274.70 |
| Beta (1Y) | 0.66 |
| Dividend Yield | 0.00% |
1. Healthcare Services-88.5% 2. Manufacturing & Trading of Implants-11.5%
Shalby Ltd is trading at ₹176.84, with a market capitalisation of ₹1,901 Cr.
Shalby Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Assisted Living Facilities and Services).
Shalby Ltd has a P/E of 54.7 and a return on equity of 3.47%.